R-Biopharm

R-Biopharm

Darmstadt, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

R-Biopharm AG is a long-established, privately-held German company specializing in the development and commercialization of diagnostic assays and analytical solutions. It operates in two core sectors: clinical diagnostics for human health and food & feed safety analysis. With a broad portfolio of products sold internationally, the company is a stable, revenue-generating entity focused on providing reliable testing for healthcare and quality control applications. Its recent expansion into 'Nutrition Care' indicates a strategic move towards personalized wellness and preventative health services.

Autoimmune DiseasesInfectious DiseasesEndocrinologyNutrition & Wellness

Technology Platform

Immunoassay (ELISA, lateral flow) and molecular diagnostic (PCR) platforms for the detection of allergens, pathogens, mycotoxins, hormones, and disease biomarkers in clinical and food safety applications.

Opportunities

Growth is driven by increasing global demand for preventative healthcare diagnostics and stringent food safety regulations.
The expansion into Nutrition Care offers a new service-based revenue stream by integrating diagnostic data with personalized wellness programs.

Risk Factors

Faces intense competition from larger diagnostic conglomerates and risks technological disruption from novel testing platforms.
Regulatory hurdles in both clinical (IVDR/FDA) and food safety sectors pose significant challenges to market access and product approval.

Competitive Landscape

Operates in highly competitive markets dominated by global giants like Roche, Abbott, Thermo Fisher, and bioMérieux. Competes on the basis of specialized assay menus, reliability, and application expertise rather than scale, also facing competition from niche players in specific test segments.